RecruitingNCT04625556

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome


Sponsor

Yonsei University

Enrollment

3,000 participants

Start Date

Dec 19, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Genitourinary malignancies such as prostate cancer, renal cell cancer, and bladder cancer in Korean population have been increased due to the aged population and the westernized lifestyles. With the advancement of technologies, studies have found that microbiome not only affects human physiological functions, such as metabolism, immunity, and haematopoiesis, but also plays a significant role in the development and progression of malignancies. However, the investigation of microbiome in urological malignances have been limited and few studies have been reported. Therefore, the investigator tried to evaluate the usefulness of microbiome in detection and monitoring of urological malignancies in Korean population. This study aims to use microbiome in tissue, plasma, stool and urine for the diagnosis, disease progression monitoring and therapeutic response evaluation. This study plan includes building big databases for microbiome of urological malignancies in Korean population.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is building a registry of patient information and biological samples to better understand urologic cancers — including prostate, kidney, bladder, and ureter cancers — by analyzing the bacteria naturally present in the body (the microbiome). Researchers hope this will lead to more personalized treatments. **You may be eligible if...** - You have been diagnosed with prostate, kidney, bladder, or ureter cancer - You had surgery for one of these cancers at Severance Hospital (Sinchon) between October 2020 and October 2030 - You are willing to share your health information and tissue samples for research **You may NOT be eligible if...** - You do not agree to participate or share your information - You are considered a vulnerable individual who may be susceptible to pressure or lacks the ability to make independent decisions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Yonsei Severance Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04625556


Related Trials